<?xml version="1.0" encoding="UTF-8"?>
<p>Specific components or fractions of mānuka oil, such as leptospermone (and its derivatives, grandiflorone and myrigalone A), have also been identified to possess antibacterial activity [
 <xref rid="B19-pharmaceuticals-13-00343" ref-type="bibr">19</xref>,
 <xref rid="B45-pharmaceuticals-13-00343" ref-type="bibr">45</xref>]. Leptospermone had the strongest inhibitory effect against foodborne Gram positive bacteria, such as 
 <italic>Listeria monocytogenes, S. aureus and S. intermedius</italic> (
 <xref rid="pharmaceuticals-13-00343-t002" ref-type="table">Table 2</xref>), using both dilution assay and agar diffusion assay (≥30 mm inhibition zone on treatment with 1 and 2 mg/disc) [
 <xref rid="B19-pharmaceuticals-13-00343" ref-type="bibr">19</xref>]. Leptospermone and its derivative 1,2,3-cyclohexanetrione-1,3-dioxime had strong inhibitory effects against intestinal bacteria, 
 <italic>Clostridium difficle</italic> and 
 <italic>C. perfringens</italic> (inhibitory zone ranged between 20 and &gt;30 mm on treatment with 2 or 5 mg/disc) [
 <xref rid="B19-pharmaceuticals-13-00343" ref-type="bibr">19</xref>]. The derivative 1,2,3-cyclohexanetrione-1,3-dioxime had a strong inhibitory effect against 
 <italic>Bifidobacterium breve</italic> and 
 <italic>B. longum</italic> (≥30 mm inhibition zone on treatment with 5 mg/disc) but leptospermum had no effect on these strains. Neither fractions were effective against 
 <italic>Lactobacillus casei</italic>, a non-pathogenic probiotic [
 <xref rid="B19-pharmaceuticals-13-00343" ref-type="bibr">19</xref>]. 
</p>
